Stocks TelegraphStocks Telegraph
Stock Ideas

JAZZ Stock Performance and Key Statistics

NASDAQ : JAZZ

Jazz Pharmaceuticals

$243.82
-3.09-1.25%
At Close 4:00 PM
56.82
B-ESG ScoreESG Rating

stock performance chart

JAZZ Fundamental Analysis

Based on recent data, Jazz Pharmaceuticals plc (JAZZ) shows an Average True Range (ATR) of 5.71 and an Enterprise Value of 11.34B. Its average trading volume over the past 3 months is 930.5K, indicating liquidity. These fundamental metrics provide insight into JAZZ's underlying financial health and market activity.

ATR5.71
Enterprise Value11.34B
Avg Vol (3 Months)930.5K
Avg Vol (10 Days)805.57K

JAZZ Technical Analysis Indicators

Jazz Pharmaceuticals plc (JAZZ) technical indicators as of July 10, 2026: the SMA 20 is 11.23%, SMA 50 at 11.87%, and SMA 200 at 36.99%. The RSI 14 value is 70.25, suggesting its current momentum. These technical analysis signals help assess JAZZ's price trends and potential future movements.

SMA 2011.23%
SMA 5011.87%
SMA 20036.99%
RSI 1470.25

JAZZ Stock Performance Overview

Jazz Pharmaceuticals plc (JAZZ) stock performance overview as of July 10, 2026: The 52-week high is $250.49 (currently -4.3% below), and the 52-week low is $105 (currently 97.9% above). Over the past year, JAZZ's performance is 36.91%, compared to the S&P 500's 5.16% change.

52-Week High250.49
52-Week High Chg-4.30%
52-Week Low105
52-Week Low Chg+97.90%
S&P 500 52-Week Chg5.16%

Jazz Pharmaceuticals plc (JAZZ) Historical Stock Performance

According to market data, Jazz Pharmaceuticals plc (JAZZ) stock's recent performance metrics show that over the last month, JAZZ is 1.8%, with a Year-to-Date (YTD) performance of -1.25%. Over the past year, the stock has seen a 36.91% change. These figures summarize JAZZ's price movements across various periods, reflecting its historical returns.

Period1 Week1 MonthQuarterHalf Year1 YearYTD
High250.49250.49250.49250.49250.49250.49
Low238.42220.74184.18156.95105156.95
Performance+2.57%+1.80%+23.39%+49.03%+36.91%-1.25%

Industry Analysis and Valuation

According to current financial data, JAZZ stock's P/E (TTM) ratio is 588.67, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for JAZZ, including P/S (3.42), P/B (3.30), and P/FCF (12.17), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.

ValuationJAZZSector MedianIndustry AvgS&P 500
P/E (TTM)588.67-1.22-194.0232.59
P/S (TTM)3.423.68466.985.98
P/B (TTM)3.317.6411.135.32
P/FCF (TTM)12.17-16.39-599.6530.1

Frequently Asked Questions

How is JAZZ price-to-earnings ratio currently?
JAZZ has a current P/E ratio of 588.67
How are JAZZ's price-to-sale and price-to-book ratios?
The JAZZ stock has a trailing twelve month price-to sales (P/S) ratio of 3.42 while its price-to-book (P/B) value is 3.3.
Is Jazz Pharmaceuticals plc's price-to-cashflow ratio high or low?
JAZZ's price-to-free-cashflow (P/FCF) ratio is 12.17, an indicator that is currently being trending upward.
What's current simple moving average (SMA) for JAZZ?
Based on JAZZ's recent bid, its distance from 20 days simple moving average is 11.23%. It is 11.87% apart from 50 days simple moving average, and it is 36.99% apart from 200 days simple moving average.
What is the 52-week price range for JAZZ?
The 52-week high for JAZZ is $250.49 which is -4.3% away from the current price level whereas the distance of that from the 52-week low of $105.00 stands at 97.9%.
An overview of JAZZ's stock performance: how did it fare?
The performance of JAZZ stock was not encouraging with most of its significant price indicators in red. Jazz Pharmaceuticals plc(NASDAQ: JAZZ) shares have moved downward -1.25% or - $3.09 in the latest trading session and have lost -1.25% year-to-date (YTD). The stock has gained nearly 36.91% over the past year. After moving 23.39% over the trailing 3-month period, the stock is 49.03% higher in the 6-month period. Looking at its performance over the shorter term, it'sgained 2.57% a week and 1.8% a month.
What is JAZZ's 14-day relative strength index (RSI)?
The current 14-day RSI for JAZZ stock is 70.25. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
For JAZZ, what is the average true range (ATR) for the past two weeks?
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Jazz Pharmaceuticals plc (JAZZ) has a 14-day ATR of 5.71.
What is JAZZ's current enterprise value?
After closing at $246.91 with 62.82M of its shares outstanding, the current enterprise value of JAZZ is roughly 11.34B.
Over the past year, how has the stock price of JAZZ changed?
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is up 36.91% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 5.16%. JAZZ stock price is also down -1.25% on its value in year-to-date trading.
What is the average trading volume for JAZZ shares?
The number outstanding shares of JAZZ is 62.82M, and of these 96.65% shares are freely available for trading. On average, JAZZ stock has traded 805.57K shares per day for the past 10 days. A total of 626.45K shares changed hands during the last trading session with the average session volume of 939.31K shares.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph